Asoxime (chloride)
(Synonyms: HI-6) 目录号 : GC15438
An AChE reactivator
Cas No.:34433-31-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
IC50: 8.9 μM: blocks AChE in human; 126 μM: inhibits acetylcholinesterase (AChE) in bovine; 160 μM: blocks muscarinic acetylcholine receptor M1, M2, M3 and M4 in mouse.
Asoxime, also known as HI-6, is an asymmetric bis-pyridinium aldoxime and reactivates AChE via nucleophilic attack of oximate anions on organophosphate-AChE conjugates.
AChE, one of the primary targets of organophosphates, is inactivated by organophosphates via reacting covalently with the active center serine, which blocks the hydrolyzation of acetylcholine at peripheral and central synapses. Additionally, the accumulation of acetylcholine leads to an over-stimulation of cholinergic receptors, which disrupts a variety of biological functions.
In vitro: HI-6 showed a bacteriostatic effect on Francisella tularensis (F. tularensis) and inhibited the growth of F. tularensis when treated with 100 mM HI-6 [1].
In vivo: Female BALB/c mice, infected by F. tularensis, were administrated subcutaneously with 100 μl HI-6 for ten days. The lower dose of HI-6 yielded in different symptoms and mortality. Compared to mice injected only with tularemia, groups of mice exposed to the lower dose of HI-6 showed a decline in mortality, which can be explained via higher efficacy of bacteriostatic effect while the toxic effect was decreased [1]. Female Wistar rats were treated intramuscularly with HI-6 at a dose of 15.6 or 156 mg/kg for one day. The level of thiobarbituric acid reactive substances was increased, which was triggered by HI-62 [2].
References:
[1]. Pohanka, M., Pavli, O., Pikula, J., Treml, F., & Kuca, K. Modulation of Tularemia Disease Progress by the Bisquaternary Pyridinium Oxime HI-6. Acta Veterinaria Brno. 2010; 79(3): 443-448.
[2]. Pohanka, M., Sobotka, J., Svobodova, H., & Stetina, R. Sulfur mustard induced oxidative stress and its alteration using asoxime (HI-6). Interdisciplinary Toxicology. 2013; 6(4).
| Cas No. | 34433-31-3 | SDF | |
| 别名 | HI-6 | ||
| 化学名 | 1-[[[4-(aminocarbonyl)pyridinio]methoxy]methyl]-2-[(hydroxyimino)methyl]-pyridinium, dichloride | ||
| Canonical SMILES | O/N=C\C1=CC=CC=[N+]1COC[N+]2=CC=C(C(N)=O)C=C2.[Cl-].[Cl-] | ||
| 分子式 | C14H16N4O3 • 2Cl | 分子量 | 359.2 |
| 溶解度 | ≤10mg/ml in PBS(pH7.2) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.784 mL | 13.9198 mL | 27.8396 mL |
| 5 mM | 0.5568 mL | 2.784 mL | 5.5679 mL |
| 10 mM | 0.2784 mL | 1.392 mL | 2.784 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。